[Treatment with somatostatin of pancreatic ascites].
Pancreatic ascites is an entity defined as amylase levels up to 1.000 U/l in ascitic liquid. Frequently, it is secondary to a rupture of pancreatic ductus or pseudocyst and foreward communication to peritoneal space. We present a male diagnosed of calcified alcoholic chronic pancreatitis with pancreatic ascites secondary to a pseudocyst. Combination of parenteral nutrition and sintetic cyclic somatostatin was efficient. It would act by reducing pancreatic secretion in a long-term manner, which is the final purpose of the treatment. This association would be considered as a former tool in ascitic pancreatic patients, evacuatory punction or delayed surgery been relegated to a conservatory treatment failure or when primary pathology indicate it.
Gómez
J
J
Servicio de Medicina Interna, Ciudad Sanitaria La Paz, Madrid.
Gallego
P
P
Cobo
J
J
Medraño
J C
JC
Molina
F
F
D001201:Ascites / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010182:Pancreatic Diseases / Q000188:drug therapy*; D013004:Somatostatin / Q000627:therapeutic use*
D013004:Somatostatin
Tratamiento con somatostatina en la ascitis pancréatica.